Migrena z aurą
Epidemiologia
Migrena z aurą (MA) dotyczy około 25-33% pacjentów z migreną, z roczną częstością występowania w USA wynoszącą 5,3% u kobiet i 1,9% u mężczyzn. Szczyt zachorowalności przypada u chłopców około 5. roku życia (7/1000 osobolat) oraz u dziewcząt w wieku 12-13 lat (14/1000 osobolat). Aura wzrokowa jest dominującym typem aury, występującym u 98-99% pacjentów, a zaburzenia czuciowe i mowy pojawiają się odpowiednio u około 36% i 10% chorych. Czas trwania aury mieści się zwykle w przedziale 5-60 minut, choć u części pacjentów objawy mogą trwać dłużej, co wymaga ponownej oceny definicji przedłużonej aury. Migrena z aurą cechuje się znacznym nakładaniem z migreną bez aury, gdyż do 81% pacjentów doświadcza obu form ataków.
Epidemiologia migreny z aurą
Migrena z aurą (MA) stanowi istotny problem zdrowotny, dotyczący znacznej części populacji pacjentów z migreną. Około jednej trzeciej osób cierpiących na migrenę doświadcza przemijających objawów neurologicznych określanych jako aura.123 Według niektórych badań aura migrenowa występuje u około 25-30% wszystkich osób z migreną, czyniąc ją powszechnym, choć nie dominującym podtypem tej choroby.45
Częstotliwość występowania w populacji ogólnej
W Stanach Zjednoczonych roczna częstość występowania migreny z aurą wynosi 5,3% u kobiet (co stanowi 30,8% wszystkich kobiet z migreną) oraz 1,9% u mężczyzn (32% wszystkich mężczyzn z migreną).67 Badania przeprowadzone w Danii wykazały, że 32% osób cierpiących na migrenę zawsze doświadcza migreny z aurą, podczas gdy kolejne 8% cierpi zarówno na migrenę z aurą, jak i bez aury.8 W innym badaniu stwierdzono, że migrena z aurą z bólem głowy lub bez niego stanowiła 38% wszystkich przypadków migreny.9
Globalnie, migrena dotyka około miliarda osób, co czyni ją jednym z najbardziej rozpowszechnionych zaburzeń neurologicznych na świecie.10 Badanie Global Burden of Disease (GBD) szacuje światową częstość występowania aktywnej migreny (z atakami w ciągu ostatniego roku) na 13,6% (17,7% kobiet i 9,5% mężczyzn).11 Biorąc pod uwagę, że około 30% osób z migreną doświadcza aury, można oszacować globalną częstość występowania migreny z aurą na poziomie około 4% populacji ogólnej.1213
Różnice związane z płcią
Migrena ogólnie występuje częściej u kobiet niż u mężczyzn, z roczną częstością występowania wynoszącą 17% u kobiet i 6% u mężczyzn.1415 Badania wykazują, że stosunek kobiet do mężczyzn cierpiących na migrenę wynosi około 3:1, a w wieku okołomenopauzalnym nawet 4:1.16 Ta dysproporcja między płciami jest szczególnie widoczna w przypadku migreny bez aury, natomiast w migrenie z aurą różnice między płciami są nieco mniej wyraźne.17
Jednakże, migrena z aurą, podobnie jak inne warianty migreny, również charakteryzuje się przewagą występowania u kobiet, ze stosunkiem kobiet do mężczyzn wynoszącym około 1:3.18 Tę różnicę przypisuje się w dużej mierze wahaniom hormonalnym w cyklu miesiączkowym, podczas ciąży i menopauzy.19
Rozkład wiekowy
Częstość występowania migreny z aurą wykazuje specyficzny rozkład wiekowy. U chłopców szczyt zachorowalności na migrenę z aurą występuje około 5. roku życia (7 na 1000 osobolat), podczas gdy u dziewcząt szczyt przypada na okres około 12-13 lat (14 na 1000 osobolat).202122
Ogólnie częstość występowania migreny zaczyna rosnąć w okresie dojrzewania i nadal wzrasta do wieku 35-39 lat, po czym następuje spadek w późniejszym okresie życia, szczególnie po menopauzie.23 W przypadku migreny z aurą, w populacjach przedpokwitaniowych i pomenopauzalnych, ten podtyp migreny jest nieco częstszy niż wśród osób w wieku 15-50 lat.24
Warto zaznaczyć, że migrenę z aurą rozpoznaje się u osób w szerokim zakresie wiekowym – raportowany wiek wystąpienia waha się od średnio 11,9 lat (zakres 4-17) do średnio 21 lat (zakres 5-77).25
Charakterystyka kliniczna występowania
W jednym z badań stwierdzono, że 54,9% pacjentów z migreną z aurą cierpiało na mniej niż jeden atak miesięcznie, a 9,7% doświadczało więcej niż trzech ataków miesięcznie. W innym badaniu średnia liczba epizodów migreny z aurą na rok na pacjenta wynosiła 29 (od mniej niż jednego do 156).26
Czas trwania aury migrenowej jest uznawany za typowy, gdy mieści się w przedziale od pięciu do sześćdziesięciu minut. Kryteria klasyfikacyjne określają aurę trwającą dłużej niż godzinę i krócej niż tydzień jako prawdopodobną migrenę z aurą. Aura wzrokowa trwa dłużej niż godzinę u 6-10% pacjentów. Inne objawy aury mogą również trwać dłużej niż godzinę: aura somatosensoryczna u 14-27% pacjentów, a aura afatyczna u 17-60% pacjentów.27 Badania sugerują jednak, że należy ponownie rozważyć definicję przedłużonej aury, ponieważ u 95% pacjentów objawy aury trwają krócej niż 4 godziny.28
Do 81% osób z migreną z aurą doświadcza również ataków migreny bez aury, co wskazuje na znaczne nakładanie się tych dwóch podtypów.2930
Typy aury migrenowej
Aura wzrokowa jest zdecydowanie najczęstszym typem aury migrenowej, występującym u 98-99% pacjentów z aurą migrenową.3132 W prospektywnym badaniu z użyciem dziennika objawy aury wzrokowej zostały skwantyfikowane następująco:
- 30% – błyski jasnego światła
- 25% – mglisty/rozmazany obraz
- 24% – zygzakowate lub postrzępione linie
- 23% – mroczki (skotomy)
- 19% – fosfeny
- 12% – migotliwe światło33
Zaburzenia czuciowe występują u około 36% pacjentów z aurą, a zaburzenia mowy u około 10%.34 Rzadsze manifestacje aury migrenowej obejmują parosmię (zaburzenia węchu), dysfagię (trudności w przełykaniu), dysgeuzję (zaburzenia smaku), hipokinezję (zmniejszona ruchomość), paramnezję (zaburzenia pamięci), halucynacje słuchowe i zmiany funkcji poznawczych.35
Migrena z aurą jako czynnik ryzyka
Migrena z aurą jest związana ze zwiększonym ryzykiem udaru niedokrwiennego.36 Liczne badania, w tym pięć metaanaliz, wykazały związek między migreną z aurą a zwiększonym ryzykiem udaru niedokrwiennego, przy czym ryzyko względne jest dwukrotnie większe u osób z MA w porównaniu z osobami bez migreny.37
Związek między migreną a udarem niedokrwiennym jest silniejszy u:
- kobiet
- kobiet poniżej 45 roku życia
- kobiet stosujących doustne środki antykoncepcyjne
- kobiet palących tytoń38
Ryzyko jest większe u osób z aktywną migreną (tj. z atakiem migrenowym w ciągu ostatnich 12 miesięcy) i wyższą częstotliwością ataków. Jednak nie ma jednoznacznych dowodów na to, że ciężkość ataków migrenowych wpływa na ryzyko udaru niedokrwiennego.39
W jednym z dużych prospektywnych badań wykazano, że kobiety doświadczające migreny z aurą są narażone na większe ryzyko wszystkich typów udaru, w tym niedokrwiennego i krwotocznego.40 Badania obrazowe wykazały również, że migrena, zwłaszcza z aurą, jest niezależnym czynnikiem ryzyka zmian o wysokim sygnale w obrazowaniu mózgu.41 W jednym z badań tylko uczestnicy, którzy mieli migrenę z aurą, mieli ponad trzykrotnie zwiększone ryzyko zawału mózgu (OR 3,4; 95% CI 1,2-9,3).42
Badania wskazują również na zwiększone ryzyko innych chorób sercowo-naczyniowych u osób z migreną z aurą, w tym zawału serca, nadciśnienia tętniczego, żylnej choroby zakrzepowo-zatorowej i migotania przedsionków.43 Kobiety z migreną z aurą mają również zwiększone ryzyko zgonu z przyczyn sercowo-naczyniowych w porównaniu z osobami bez migreny.44
Implikacje dla zdrowia publicznego
Migrena, w tym migrena z aurą, stanowi znaczne obciążenie dla zdrowia publicznego i systemów opieki zdrowotnej. Migrena jest siódmą główną przyczyną utraconych lat życia z powodu niepełnosprawności na całym świecie i trzecią przyczyną niepełnosprawności u osób poniżej 50 roku życia.45 Jest wiodącą przyczyną niepełnosprawności wśród zaburzeń neurologicznych, odpowiadając za ponad połowę wszystkich lat życia z niepełnosprawnością.46
Całkowity roczny koszt ekonomiczny migreny w Australii wynosi 35,7 miliarda dolarów australijskich, w tym 14,3 miliarda w kosztach systemu opieki zdrowotnej, 16,3 miliarda w kosztach produktywności i 5,1 miliarda w innych kosztach.47 W Stanach Zjednoczonych koszt ekonomiczny wynikający z utraty czasu pracy z powodu migreny w amerykańskiej sile roboczej przekracza 13 miliardów dolarów rocznie, przy czym większość tej kwoty stanowi obniżona wydajność pracy.48
Nadzór i monitorowanie epidemiologiczne
Monitorowanie epidemiologiczne migreny z aurą jest istotne z kilku powodów. Po pierwsze, migrena z aurą jest związana ze zwiększonym ryzykiem chorób sercowo-naczyniowych, co czyni ją ważnym markerem ryzyka wymagającym nadzoru.49 Algorytm QRISK3 został niedawno opracowany i zwalidowany w celu przewidywania 10-letniego ryzyka chorób sercowo-naczyniowych u mężczyzn i kobiet w wieku 25-84 lat, a włączenie migreny do tego algorytmu wskazuje na jej znaczenie w przewidywaniu ryzyka chorób sercowo-naczyniowych.50
Po drugie, dokładne monitorowanie epidemiologiczne jest niezbędne do poprawy charakterystyki choroby i umożliwienia dokładnej diagnozy w praktyce klinicznej.51 Złożone i wieloaspektowe manifestacje migreny z aurą są trudne do retrospektywnego przypomnienia, co podkreśla potrzebę większej liczby badań prospektywnych.52
Po trzecie, migrena z aurą jest częstym „mimikrem” udaru i często stanowi podstawę do wdrożenia ostrej terapii trombolitycznej. W jednym z przeglądów, w którym nieco poniżej 7% pacjentów otrzymało niewłaściwe leczenie trombolityczne, migrena z aurą stanowiła 18% tych przypadków.53 Dlatego ważne jest prawidłowe zidentyfikowanie aury, ponieważ osoby z migreną z aurą mogą potencjalnie rozwinąć przewlekłą postać choroby, mają wyższe ryzyko udaru i powinny mieć inny plan leczenia.54
Wyzwania w badaniu migreny z aurą
Istnieje kilka wyzwań związanych z dokładnym badaniem epidemiologii migreny z aurą. Klasyfikacja migreny, a zwłaszcza migreny z aurą, w badaniach populacyjnych jest trudna.55 Ponadto, złożone i wieloaspektowe manifestacje aury migrenowej są trudne do retrospektywnego przypomnienia, co podkreśla potrzebę większej liczby badań prospektywnych.56
Innym wyzwaniem jest to, że obecność bólu głowy po przemijających objawach neurologicznych niekoniecznie oznacza, że objawy te są zgodne z diagnozą migreny z aurą, ponieważ atak podobny do migreny (z aurą lub bez) może być również wywołany przez niedokrwienne zdarzenia naczyniowe.57
Badacze podkreślają potrzebę udoskonalonej klasyfikacji migrenowych objawów wzrokowych aury i proponują, aby oficjalna lista objawów wzrokowych została opracowana w tym celu, najlepiej w kontekście Międzynarodowej Klasyfikacji Bólów Głowy Międzynarodowego Towarzystwa Bólu Głowy.58
Znaczenie w kontekście badawczym
Migrena z aurą zyskuje coraz większe zainteresowanie w badaniach naukowych ze względu na jej potencjalne implikacje dla zrozumienia innych zaburzeń neurologicznych i mechanizmów bólu. Niedawne badania na myszach sugerują nowy mechanizm, w którym faza aury przed bólem głowy tymczasowo zmienia skład płynu mózgowo-rdzeniowego. Ten zmieniony płyn przemieszcza się przez wcześniej nieznany anatomiczny punkt do nerwów w czaszce, gdzie aktywuje receptory bólu i stanu zapalnego.59
Inni badacze odkryli związek między migreną z aurą a doświadczeniami bliskimi śmierci (NDE). W badaniu opartym na crowdsourcingu migrena z aurą była predyktorem NDE, przy czym 13% osób z migreną z aurą doświadczyło NDE w porównaniu z 6,1% osób bez migreny z aurą (p<0,001, test chi-kwadrat, iloraz szans = 2,29).60
Co ciekawe, niektórzy badacze sugerują potencjalny związek między migreną z aurą a zaburzeniami ze spektrum autyzmu. Teorią jest, że nagła utrata wzroku, niewyjaśnione ruchy i zygzakowate wzory migreny z aurą mogą zakłócać wyjątkową dynamikę udanego przywiązania między matką a dzieckiem we wczesnym niemowlęctwie. Postuluje się, że doświadczenie aury migrenowej może zakłócać postrzeganie przez niemowlę stabilnej rzeczywistości i zagrażać bezpieczeństwu relacji matka-dziecko, potencjalnie przyczyniając się do wzorców strachu-konfliktu i niepowodzeń rozwojowych związanych z autyzmem niemowlęcym.61
Badania te, chociaż nadal są na wczesnym etapie, podkreślają potencjalne znaczenie migreny z aurą dla zrozumienia różnych mechanizmów neurologicznych i wskazują, że dalsze badania w tej dziedzinie mogą prowadzić do istotnych postępów w diagnozowaniu, wczesnym leczeniu i zapobieganiu różnym zaburzeniom.
Implikacje kliniczne
Dokładna diagnoza migreny z aurą ma kluczowe znaczenie dla właściwego leczenia i zarządzania ryzykiem. Ze względu na zwiększone ryzyko udaru i innych chorób sercowo-naczyniowych u osób z migreną z aurą, ważne jest zidentyfikowanie i modyfikacja czynników ryzyka naczyniowego.62
Szczególną uwagę należy zwrócić na kobiety z migreną z aurą, które stosują hormonalną antykoncepcję zawierającą estrogeny, ponieważ znacznie zwiększa to ryzyko udaru.63 Podobnie, palenie tytoniu przez kobiety z migreną z aurą dodatkowo zwiększa ryzyko udaru.64
Ważne jest jednak, aby nie powodować niepotrzebnego niepokoju. Większość pacjentów z migreną ma migrenę bez aury i nie ma zwiększonego lub tylko nieznacznie zwiększonego ryzyka udaru, dlatego powinni być uspokajani zamiast straszeni.65 Niemniej jednak, migrenę z aurą należy uznać za ważny marker ryzyka udaru, oparty na obecnych dowodach.66
W kontekście leczenia, zabiegi profilaktyczne stosowane w migrenie z aurą są takie same jak w migrenie bez aury, oparte na nielicznych randomizowanych badaniach klinicznych poświęconych specjalnie migrenie z aurą.67 Identyfikacja kluczowych biomarkerów, w szczególności receptora serotoniny 1F i peptydu związanego z genem kalcytoniny (CGRP), zrewolucjonizowała podejścia do leczenia, a antagoniści CGRP, takie jak EMGALITY (galcanezumab-gnlm) firmy Eli Lilly i AJOVY (fremanezumab-vfrm) firmy Teva, zdobyły znaczący udział w rynku.68
| Aspekt epidemiologiczny | Migrena z aurą | Migrena bez aury |
|---|---|---|
| Częstość występowania w populacji migrenowej | Około 25-33% pacjentów z migreną | Około 67-75% pacjentów z migreną |
| Roczna częstość występowania w USA (kobiety) | 5,3% | Około 12% |
| Roczna częstość występowania w USA (mężczyźni) | 1,9% | Około 4% |
| Szczyt zachorowalności u chłopców | Około 5 roku życia (7/1000 osobolat) | 10-11 lat (10/1000 osobolat) |
| Szczyt zachorowalności u dziewcząt | 12-13 lat (14/1000 osobolat) | 14-17 lat (18,9/1000 osobolat) |
| Ryzyko udaru niedokrwiennego | Dwukrotnie zwiększone | Brak istotnego wzrostu |
| Najczęstszy typ aury | Aura wzrokowa (98-99% przypadków) | Nie dotyczy |
| Częstość występowania zaburzeń czuciowych w aurze | Około 36% | Nie dotyczy |
| Częstość występowania zaburzeń mowy w aurze | Około 10% | Nie dotyczy |
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Clinical features of migraine with aura: a REFORM study | The Journal of Headache and Pain | Full Texthttps://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01718-1
About one-third of persons with migraine experience transient neurologic symptoms, referred to as aura. […] Despite its widespread prevalence, comprehensive clinical descriptions of migraine with aura remain sparse. […] Therefore, we aimed to provide an in-depth phenotypic analysis of aura symptoms and characteristics in a cross-sectional study of a large sample of adults diagnosed with migraine with aura. […] Participants were adults diagnosed with migraine aura, reporting 4 monthly migraine days in the preceding 3 months. […] This study offers a detailed clinical depiction of persons with migraine with aura, who were predominantly enrolled from a tertiary care unit. […] The findings highlight potential gaps in the available literature on migraine with aura and should bolster clinicians’ acumen in diagnosing migraine with aura in clinical settings.
- #2 Clinical features of migraine with aura: a REFORM study | The Journal of Headache and Pain | Full Texthttps://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01718-1
Among those with migraine, about one-third experience migraine with aura (MA), characterized by transient neurologic symptoms. […] While the 3rd edition of the International Classification of Headache Disorders (ICHD-3) provides valuable insights into the clinical features of aura, the available evidence from observational studies often lacks the detail necessary for a thorough understanding. […] Addressing this critical gap is paramount to improving disease characterization and enabling accurate diagnoses in clinical practice. […] Our findings will thus provide valuable insights for clinical practice and serve as a foundation for further research in this field. […] The study protocol received approval from the Health Research Ethics Committee of the Capital Region of Denmark, and all participants provided written informed consent before undergoing any study-related assessments or procedures.
- #3 Migraine with Aura | American Headache Societyhttps://americanheadachesociety.org/resources/primary-care/migraine-with-aura
Approximately one-third of those with migraine experience aura, a sensory experience that occurs before or during an attack. […] Its important to correctly identify aura because those who have migraine with aura can potentially turn chronic, have a higher risk of stroke, and should have a different treatment plan. […] A team of researchers working in France and the U.S. has demonstrated in a large prospective study that women who experience migraine with aura are at greater risk of all types of stroke including ischemic and hemorrhagic stroke as well as all strokes.
- #4 Migraine With Aura: Symptoms, Causes, and Treatmenthttps://www.verywellhealth.com/migraine-with-aura-headache-4171966
Migraine with aura is experienced by 25% to 30% of people with migraines. […] Women who have migraine with aura have a slightly increased risk of stroke, especially if they smoke or take birth control pills. […] It is important to consult with a healthcare provider to get an official diagnosis of migraine with aura and to rule out other serious health conditions.
- #5 Migraine – Epidemiology and burden – Neurotoriumhttps://neurotorium.org/slidedeck/migraine-epidemiology-and-burden/
Migraine – Epidemiology and burden Migraine epidemiology Prevalence of migraine with and without aura Although estimates vary, approximately 20% of patients with migraine experience aura, albeit not during every attack. Migraine has a higher prevalence among women than it does among men. A number of studies have found that women with migraine report a higher headache-related disability than men. […] The Global Burden of Disease (GBD) study takes a standardised approach to estimating incidence, prevalence, and years lived with disability (YLD) of various diseases and health states, often segmenting the data by age, sex, year, and geography.
- #6 The Clinical Features of Migraine With and Without Aurahttps://practicalneurology.com/diseases-diagnoses/headache-pain/the-clinical-features-of-migraine-with-and-without-aura/30665/
In the United States, the one year period prevalence of migraine with aura is 5.3 percent in females (30.8 percent of female migraineurs) and 1.9 percent in males (32 percent of male migraineurs). Up to 81 percent of those with migraine with aura also have attacks of migraine without aura. The reported age of onset ranges from a mean of 11.9 years (range 4-17) to a mean of 21 years old (range 5-77). In one study, 54.9 percent of patients suffered from less than one attack per month and 9.7 percent from more than three attacks per month. In another study, the mean of migraine with aura episodes/year/patient was reported to be 29 (ranging from less than one to 156). […] Migraine aura is considered to be of typical duration when lasting between five and sixty minutes. The criteria label aura lasting longer than an hour and less than a week as probable migraine with aura. Visual aura has been reported as lasting more than one hour in 6-10 percent of patients. Other aura symptoms can also last more than one hour as follows: somatosensory aura in 14-27 percent and aphasic aura in 17-60 percent of patients.
- #7 CRSToday | The Clinical Features of Migraine With and Without Aurahttps://crstoday.com/articles/2014-mar/the-clinical-features-of-migraine-with-and-without-aura
Migraine is one of the disorders most commonly seen by neurologists and ophthalmologists. Only about 56% of migraineurs know that they have the condition, however, because they often misdiagnose their headaches as ocular strain, sinus headaches, or stress headaches. […] In a given year, migraine has a prevalence of 12% (17.1% in women and 5.6% in men). Annually, some 35 million people suffer migraine in the United States. The cumulative incidence of this disorder by age 85 is 18.5% in men and 44.3% in women, with onset before the age of 25 in 50% of cases, before the age of 35 years in 75%, and over the age of 50 in only 2%. The median age of onset is 25 years. Approximately 8% of boys and 11% of girls have migraine. Chronic migraine with attacks occurring on 15 or more days per month for at least 3 months affects about 3.2 million people per year in the United States, 80% of whom are women. […] In a given year in the United States, the prevalence of migraine with aura is 5.3% in women (30.8% of female migraineurs) and 1.9% in men (32% of male migraineurs). As many as 81% of those who have migraine with aura also have attacks of migraine without aura.
- #8 Migraine with Aura | Melbourne Headache Centrehttps://melbourneheadachecentre.com.au/conditions/migraine-with-aura/
Migraine aura is one of the most universally thought of symptoms of migraine by the general public, despite affecting less than 30% of migraine sufferers. […] In several large population based studies in Denmark researchers found 32% of people who suffered migraine always suffered migraine with aura, while another 8% suffered both migraine with and without aura. A second study found that migraine aura with or without headache accounted for 38% of all migraine cases. […] A prospective diary study quantified migraine aura: 98% of respondents had visual symptoms (with 64% having 2 or more). Commonly reported were: 30% Flashes of bright light, 25% Foggy/blurred vision, 24% Zigzag or jagged lines, 23% Scotoma, 19% Phosphenes, 12% Flickering light. […] As you can see migraine aura extends to cover a wide range of presentations, with rarer examples being parosmia, dysphagia, dysgeusia, hypokinesia, paramnesia, auditory hallucinations and altered cognitive function.
- #9 Migraine with Aura | Melbourne Headache Centrehttps://melbourneheadachecentre.com.au/conditions/migraine-with-aura/
Migraine aura is one of the most universally thought of symptoms of migraine by the general public, despite affecting less than 30% of migraine sufferers. […] In several large population based studies in Denmark researchers found 32% of people who suffered migraine always suffered migraine with aura, while another 8% suffered both migraine with and without aura. A second study found that migraine aura with or without headache accounted for 38% of all migraine cases. […] A prospective diary study quantified migraine aura: 98% of respondents had visual symptoms (with 64% having 2 or more). Commonly reported were: 30% Flashes of bright light, 25% Foggy/blurred vision, 24% Zigzag or jagged lines, 23% Scotoma, 19% Phosphenes, 12% Flickering light. […] As you can see migraine aura extends to cover a wide range of presentations, with rarer examples being parosmia, dysphagia, dysgeusia, hypokinesia, paramnesia, auditory hallucinations and altered cognitive function.
- #10 Understanding the Epidemiology of Migraine Headaches – NatraCurehttps://natracure.com/blogs/natracure-blog/understanding-the-epidemiology-of-migraine-headaches?srsltid=AfmBOoqUCMfD0_bjgv8oMOQ_DmOXtpMoNLITHsEnauiUyvAzxCdUmpWy
Understanding the Epidemiology of Migraine Headaches […] Migraine is a complex neurological condition affecting over 1 billion individuals globally, placing it among the most prevalent and disabling disorders in the world (GBD 2019 Diseases and Injuries Collaborators, 2020). […] Globally, migraines are a leading cause of disability, with approximately 14.4% of the worlds population affected. This places migraines among the most prevalent non-communicable neurological disorders worldwide (Steiner et al., 2020). […] According to the Global Burden of Disease (GBD) data, migraines consistently rank within the top 10 causes of years lived with disability (YLDs), highlighting their profound impact not only on individuals but also on healthcare systems and economies at large. […] The gender disparity in migraine prevalence is particularly striking. Women are up to three times more likely to experience migraines than men, a difference largely attributed to hormonal fluctuations across the menstrual cycle, pregnancy, and menopause (Steiner et al., 2020). […] In the United States, migraines affect approximately 39 million people, equating to about 12% of the population (Buse et al., 2013).
- #11 Migraine – Statistical and Genomic Epidemiology Laboratory (SGEL)https://research.qut.edu.au/sgel/research/migraine/
Migraine is a highly prevalent disorder with frequent attacks. Nearly one in four people (up to 33% of women and 13% of men), will have recurring attacks of migraine during their life. The 2015 Global Burden of Disease (GDB) study estimated the global prevalence of active migraineurs (i.e., attacks in the past year) at 13.6% (17.7% of women and 9.5% of men); in Australia, the prevalence was estimated at 19.3% (26.5% of women and 11.7% all men). […] One in ten migraineurs will develop chronic migraine with migraine headaches on at least 15 days a month. […] Migraine is the seventh leading cause of years of life lost to disability worldwide, and the third cause of disability in under 50s. Migraine is the leading cause of disability among neurological disorders, accounting for over half of all years lived with disability. […] The total annual economic cost of migraine in Australia is $35.7bn, comprising $14.3bn in health system costs, $16.3bn in productivity costs, and $5.1bn in other costs.
- #12 Transient ischemic attack or migraine with aura? | Tidsskrift for Den norske legeforeninghttps://tidsskriftet.no/en/2023/10/clinical-review/transient-ischemic-attack-or-migraine-aura
Migraine with aura is a common stroke mimic and often the basis for acute thrombolytic therapy. […] In one review, where just under 7 % of patients had received improper thrombolytic treatments, migraine with aura accounted for 18 %. […] Migraine with aura: the criteria for typical migraine with aura have high sensitivity and high specificity. […] Around 30 % of migraine sufferers experience migraine with aura. […] Migraine has been identified as an independent risk factor for high-signal changes, especially in patients who experience aura. […] Migraine with aura can, in most cases, be distinguished from TIA by the gradual onset of symptoms with typical characteristics, sequence and duration.
- #13 Migraine aura, a predictor of near-death experiences in a crowdsourced study | bioRxivhttps://www.biorxiv.org/content/10.1101/811885v1.full-text
The observation that 24% of the participants in our survey met criteria for a migraine aura, while population-based studies have estimated this prevalence at only 4% in the general population, renders this indeed likely. […] Several studies found an association between migraine and narcolepsy, a disorder involving REM intrusion. […] For example, Yang and colleagues found a consistently higher risk of developing narcolepsy in children with migraine compared to those without, and this risk was particularly high in children with migraine with aura.
- #14 Migraine With Aura | Treatment & Management | Point of Carehttps://www.statpearls.com/point-of-care/25145
Migraine affects approximately 12% to 15% of the general population. Women encounter migraines more frequently than men, with 17% of females and 6% of males experiencing attacks each year. Migraine ranks as the fourth or fifth leading cause of emergency room visits, accounting for 3% of all emergency visits annually. […] Migraine prevalence starts to rise during puberty and continues to increase until the age of 35 to 39, with a decrease later in life, especially after menopause. Additionally, migraine ranks second only to back pain in terms of disability when comparing years of life lived with disability.
- #15 Migraine Headache: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/1142556-overview
In the United States, more than 30 million people have 1 or more migraine headaches per year. This corresponds to approximately 18% of females and 6% of males. […] Approximately 75% of all persons who experience migraines are women. Currently, 1 in 6 American women has migraine headaches. (The reported incidence of migraine in females of reproductive age has increased over the last 20 years, but this change probably reflects greater awareness of the condition.) […] The incidence of migraine with aura peaks in boys at around age 5 years and in girls at around age 12-13 years. The incidence of migraine without aura peaks in boys at age 10-11 years and in girls at age 14-17 years. […] Before puberty, the prevalence and incidence of migraine are higher in boys than in girls. After age 12 years, the prevalence increases in males and females, reaching a peak at age 30-40 years. The female-to-male ratio increases from 2.5:1 at puberty to 3.5:1 at age 40 years.
- #16
- #17 Migraine epidemiology and demographics – wikidochttps://www.wikidoc.org/index.php/Migraine_epidemiology_and_demographics
At all ages, migraine without aura is more common than migraine with aura, with a ratio of between 1.5:1 and 2:1. […] Incidence figures show that the excess of migraine seen in women of reproductive age is mainly due to migraine without aura. […] Thus in pre-pubertal and post-menopausal populations, migraine with aura is somewhat more common than amongst 15-50 year olds. […] Geographical differences in migraine prevalence are not marked. […] The incidence of migraine is related to the incidence of epilepsy in families, with migraine twice as prevalent in family members of epilepsy sufferers, and more common in epilepsy sufferers themselves.
- #18 Migraine Variants: Overview, Pathophysiology, Epidemiologyhttps://emedicine.medscape.com/article/1142731-overview
Migraine affects nearly 13% of the adult US population, with a postpubertal female-to-male ratio of 4:1. The frequency of the less common migraine variants varies with the migraine type and patient age. The prevalence of hemiplegic migraine is 0.03%; both familial and sporadic forms are equally frequent. The prevalence of the distinct alternating hemiplegic migraine of infancy is unknown. Similarly, the prevalences of ophthalmoplegic, retinal, and confusional migraine are unknown. […] Sex-related differences in prevalence may be observed in some types of migraine variants. Basilar migraine and migraine aura without headaches are more common in women than in men. Similarly, hemiplegic migraine is more common in women, with a male-to-female sex ratio of 1:3. Benign coital headache has a male-to-female ratio of 4:1.
- #19 Understanding the Epidemiology of Migraine Headaches – NatraCurehttps://natracure.com/blogs/natracure-blog/understanding-the-epidemiology-of-migraine-headaches?srsltid=AfmBOoqUCMfD0_bjgv8oMOQ_DmOXtpMoNLITHsEnauiUyvAzxCdUmpWy
Understanding the Epidemiology of Migraine Headaches […] Migraine is a complex neurological condition affecting over 1 billion individuals globally, placing it among the most prevalent and disabling disorders in the world (GBD 2019 Diseases and Injuries Collaborators, 2020). […] Globally, migraines are a leading cause of disability, with approximately 14.4% of the worlds population affected. This places migraines among the most prevalent non-communicable neurological disorders worldwide (Steiner et al., 2020). […] According to the Global Burden of Disease (GBD) data, migraines consistently rank within the top 10 causes of years lived with disability (YLDs), highlighting their profound impact not only on individuals but also on healthcare systems and economies at large. […] The gender disparity in migraine prevalence is particularly striking. Women are up to three times more likely to experience migraines than men, a difference largely attributed to hormonal fluctuations across the menstrual cycle, pregnancy, and menopause (Steiner et al., 2020). […] In the United States, migraines affect approximately 39 million people, equating to about 12% of the population (Buse et al., 2013).
- #20 Migraine Headache | AAFPhttps://www.aafp.org/pubs/afp/issues/2002/0501/p1871.html
Migraine is common worldwide. Prevalence has been reported to be between 5 and 25 percent in women and 2 and 10 percent in men. Overall, the highest incidence for migraine without aura has been reported between 10 and 11 years of age at 10 per 1,000 person-years. The incidence of migraine with aura peaks in boys around five years of age (seven per 1,000 person-years) and in girls around 12 to 13 years of age (14 per 1,000 person-years). […] Data arising from independent representative samples from Canada, the United States, several countries in Latin America, several countries in Europe, Hong Kong, and Japan demonstrate a female-to-male predominance and a peak in middle-aged women. […] Female prevalence of migraine with or without aura has a declining trend after 45 to 50 years of age.
- #21 Migraine Epidemiology | SpringerLinkhttps://link.springer.com/10.1007/978-3-540-29805-2_2419
Migraine is a prevalent under-diagnosed and under-treated medical disorder, associated with a severe impact on the quality of life of the sufferers and their families as well as an enormous economic impact on society. This essay reviews the epidemiology and burden of migraine in population studies. Epidemiological studies often focus on the incidence and prevalence of disease in defined populations. […] The incidence of migraine has been investigated in a limited number of studies. Stewart et al found that in females, the incidence of migraine with aura peaked between ages 12 and 13 (14.1 / 1000 person-years); migraine without aura peaked between ages 14 and 17 (18.9 / 1000 person-years). In males, the incidence of migraine with aura peaked several years earlier, around 5 years of age at 6.6 / 1000 person-years; the peak for migraine without aura was 10 / 1000 person-years between 10 and 11 years. […] Age and sex-specific incidence rates of migraine with and without visual aura.
- #22 Migraine Epidemiology | SpringerLinkhttps://link.springer.com/10.1007/978-3-642-28753-4_2419
Migraine is a prevalent under-diagnosed and under-treated medical disorder, associated with a severe impact on the quality of life of the sufferers and their families as well as an enormous economic impact on society. This entry reviews the epidemiology and burden of migraine in population studies. Epidemiological studies often focus on the incidence and prevalence of disease in defined populations. […] The incidence of migraine has been investigated in a limited number of studies. Stewart et al. found that in females, the incidence of migraine with aura peaked between ages 12 and 13 (14.1/1,000 person-years); migraine without aura peaked between ages 14 and 17 (18.9/1,000 person-years). In males, the incidence of migraine with aura peaked several years earlier, around 5 years of age at 6.6/1,000 person-years; the peak for migraine without aura was 10/1,000 person-years between… […] Stewart, W. F., Linet, M. S., Celentano, D. D., et al. (1993). Age and sex-specific incidence rates of migraine with and without visual aura.
- #23 Migraine With Aura | Treatment & Management | Point of Carehttps://www.statpearls.com/point-of-care/25145
Migraine affects approximately 12% to 15% of the general population. Women encounter migraines more frequently than men, with 17% of females and 6% of males experiencing attacks each year. Migraine ranks as the fourth or fifth leading cause of emergency room visits, accounting for 3% of all emergency visits annually. […] Migraine prevalence starts to rise during puberty and continues to increase until the age of 35 to 39, with a decrease later in life, especially after menopause. Additionally, migraine ranks second only to back pain in terms of disability when comparing years of life lived with disability.
- #24 Migraine epidemiology and demographics – wikidochttps://www.wikidoc.org/index.php/Migraine_epidemiology_and_demographics
At all ages, migraine without aura is more common than migraine with aura, with a ratio of between 1.5:1 and 2:1. […] Incidence figures show that the excess of migraine seen in women of reproductive age is mainly due to migraine without aura. […] Thus in pre-pubertal and post-menopausal populations, migraine with aura is somewhat more common than amongst 15-50 year olds. […] Geographical differences in migraine prevalence are not marked. […] The incidence of migraine is related to the incidence of epilepsy in families, with migraine twice as prevalent in family members of epilepsy sufferers, and more common in epilepsy sufferers themselves.
- #25 The Clinical Features of Migraine With and Without Aurahttps://practicalneurology.com/diseases-diagnoses/headache-pain/the-clinical-features-of-migraine-with-and-without-aura/30665/
In the United States, the one year period prevalence of migraine with aura is 5.3 percent in females (30.8 percent of female migraineurs) and 1.9 percent in males (32 percent of male migraineurs). Up to 81 percent of those with migraine with aura also have attacks of migraine without aura. The reported age of onset ranges from a mean of 11.9 years (range 4-17) to a mean of 21 years old (range 5-77). In one study, 54.9 percent of patients suffered from less than one attack per month and 9.7 percent from more than three attacks per month. In another study, the mean of migraine with aura episodes/year/patient was reported to be 29 (ranging from less than one to 156). […] Migraine aura is considered to be of typical duration when lasting between five and sixty minutes. The criteria label aura lasting longer than an hour and less than a week as probable migraine with aura. Visual aura has been reported as lasting more than one hour in 6-10 percent of patients. Other aura symptoms can also last more than one hour as follows: somatosensory aura in 14-27 percent and aphasic aura in 17-60 percent of patients.
- #26 The Clinical Features of Migraine With and Without Aurahttps://practicalneurology.com/diseases-diagnoses/headache-pain/the-clinical-features-of-migraine-with-and-without-aura/30665/
In the United States, the one year period prevalence of migraine with aura is 5.3 percent in females (30.8 percent of female migraineurs) and 1.9 percent in males (32 percent of male migraineurs). Up to 81 percent of those with migraine with aura also have attacks of migraine without aura. The reported age of onset ranges from a mean of 11.9 years (range 4-17) to a mean of 21 years old (range 5-77). In one study, 54.9 percent of patients suffered from less than one attack per month and 9.7 percent from more than three attacks per month. In another study, the mean of migraine with aura episodes/year/patient was reported to be 29 (ranging from less than one to 156). […] Migraine aura is considered to be of typical duration when lasting between five and sixty minutes. The criteria label aura lasting longer than an hour and less than a week as probable migraine with aura. Visual aura has been reported as lasting more than one hour in 6-10 percent of patients. Other aura symptoms can also last more than one hour as follows: somatosensory aura in 14-27 percent and aphasic aura in 17-60 percent of patients.
- #27 The Clinical Features of Migraine With and Without Aurahttps://practicalneurology.com/diseases-diagnoses/headache-pain/the-clinical-features-of-migraine-with-and-without-aura/30665/
In the United States, the one year period prevalence of migraine with aura is 5.3 percent in females (30.8 percent of female migraineurs) and 1.9 percent in males (32 percent of male migraineurs). Up to 81 percent of those with migraine with aura also have attacks of migraine without aura. The reported age of onset ranges from a mean of 11.9 years (range 4-17) to a mean of 21 years old (range 5-77). In one study, 54.9 percent of patients suffered from less than one attack per month and 9.7 percent from more than three attacks per month. In another study, the mean of migraine with aura episodes/year/patient was reported to be 29 (ranging from less than one to 156). […] Migraine aura is considered to be of typical duration when lasting between five and sixty minutes. The criteria label aura lasting longer than an hour and less than a week as probable migraine with aura. Visual aura has been reported as lasting more than one hour in 6-10 percent of patients. Other aura symptoms can also last more than one hour as follows: somatosensory aura in 14-27 percent and aphasic aura in 17-60 percent of patients.
- #28 Prolonged Aura in Migraine Is Frequent, Similar to Other Aurashttps://www.ajmc.com/view/prolonged-aura-in-migraine-is-frequent-similar-to-other-auras
A recent study has found that prolonged auras are common and are phenotypically similar to other auras. […] There is currently a limited amount of research involving prolonged aura (PA) in migraine having 1 or more aura symptoms lasting between 60 minutes and 7 days. […] Worldwide migraine is the third most common disorder and around 30% of sufferers experience migraine auras. […] The researchers recruited 224 patients from the Headache Centers of Pavia and Trondheim who suffered from migraine with aura between October 2012 and July 2014. […] Overall, the authors noted that their findings show that, phenotypically, PAs are similar to non-PAs and are fairly common with 17% of all auras being PA and with 26% of patients experiencing at least 1. […] The authors also note that their findings suggest the need to reconsider the use of the term prolonged aura, which is currently defined as more than 60 minutes and less than a week. […] Because aura symptoms lasted less than 4 hours in 95% of the cases, having that symptoms for up to 4 hours should be considered typical, they argue.
- #29 The Clinical Features of Migraine With and Without Aurahttps://practicalneurology.com/diseases-diagnoses/headache-pain/the-clinical-features-of-migraine-with-and-without-aura/30665/
In the United States, the one year period prevalence of migraine with aura is 5.3 percent in females (30.8 percent of female migraineurs) and 1.9 percent in males (32 percent of male migraineurs). Up to 81 percent of those with migraine with aura also have attacks of migraine without aura. The reported age of onset ranges from a mean of 11.9 years (range 4-17) to a mean of 21 years old (range 5-77). In one study, 54.9 percent of patients suffered from less than one attack per month and 9.7 percent from more than three attacks per month. In another study, the mean of migraine with aura episodes/year/patient was reported to be 29 (ranging from less than one to 156). […] Migraine aura is considered to be of typical duration when lasting between five and sixty minutes. The criteria label aura lasting longer than an hour and less than a week as probable migraine with aura. Visual aura has been reported as lasting more than one hour in 6-10 percent of patients. Other aura symptoms can also last more than one hour as follows: somatosensory aura in 14-27 percent and aphasic aura in 17-60 percent of patients.
- #30 CRSToday | The Clinical Features of Migraine With and Without Aurahttps://crstoday.com/articles/2014-mar/the-clinical-features-of-migraine-with-and-without-aura
Migraine is one of the disorders most commonly seen by neurologists and ophthalmologists. Only about 56% of migraineurs know that they have the condition, however, because they often misdiagnose their headaches as ocular strain, sinus headaches, or stress headaches. […] In a given year, migraine has a prevalence of 12% (17.1% in women and 5.6% in men). Annually, some 35 million people suffer migraine in the United States. The cumulative incidence of this disorder by age 85 is 18.5% in men and 44.3% in women, with onset before the age of 25 in 50% of cases, before the age of 35 years in 75%, and over the age of 50 in only 2%. The median age of onset is 25 years. Approximately 8% of boys and 11% of girls have migraine. Chronic migraine with attacks occurring on 15 or more days per month for at least 3 months affects about 3.2 million people per year in the United States, 80% of whom are women. […] In a given year in the United States, the prevalence of migraine with aura is 5.3% in women (30.8% of female migraineurs) and 1.9% in men (32% of male migraineurs). As many as 81% of those who have migraine with aura also have attacks of migraine without aura.
- #31 Clinical features of visual migraine aura: a systematic review | The Journal of Headache and Pain | Full Texthttps://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-019-1008-x
Migraine with typical aura is a highly prevalent disorder as it affects 8% of the general population. Typical migraine aura (MA) symptoms are completely reversible visual, sensory, or language disturbances. Visual aura symptoms (VASs) are by far the most common and occur in 98-99% of MAs, whereas disturbances of sensation and language occur in 36% and 10% of auras, respectively. MA is associated with an increased risk of ischemic stroke, atrial fibrillation, and patent foramen ovale. It is also often clinically challenging to differentiate MA from other conditions, particularly transient ischemic attacks and occipital epilepsy. Improved clinical characterisation of MA will likely improve the diagnostic accuracy and identification of patient subgroups at risk of comorbidity. We systematically reviewed studies of VASs in order to create a list of all visual features reported during MA. We identified 14 studies, of which only three were prospective. The low number of prospective studies is a major limitation as the complex and polyhedral manifestations of MA are difficult to recall retrospectively. MA is a risk factor for several serious cardiovascular conditions, including ischemic and haemorrhagic stroke, myocardial infarction, atrial fibrillation and perioperative stroke. Moreover, the risk of vascular incidents increases up to 13 fold with the use of combined oral contraceptives, which is important considering that the majority of migraine patients are women of reproductive age. Therefore, it is of utmost importance to correctly diagnose patients with MA in order to effectively distinguish MA from other, potentially life-threatening, conditions. We emphasize the importance of an improved classification of migraine VASs and propose that an official list of visual symptoms should be developed for this purpose, preferably within the context of the International Classification of Headache Disorders of the International Headache Society.
- #32 Prevalence and impact of visual aura in migraine and probable migraine: a population study | Scientific Reportshttps://www.nature.com/articles/s41598-021-04250-3
Visual aura (VA) presents in 98% of cases of migraine with aura. However, data on its prevalence and impact in individuals with migraine and probable migraine (PM) are limited. […] VA prevalence did not differ between these cohorts (29.4% [50/170] vs. 24.3% [82/337], p=0.219). […] VA prevalence was similar between migraine and PM. Some symptoms were more severe in the presence of VA. […] The present study aimed to compare the prevalence and impact of VA between PM and migraine using a nation-wide population-based sample in Korea. […] The prevalence of VA was not significantly different between migraine and PM. Some symptoms and comorbidities of migraine and PM with VA were more severe as compared with those of migraine and PM without VA.
- #33 Migraine with Aura | Melbourne Headache Centrehttps://melbourneheadachecentre.com.au/conditions/migraine-with-aura/
Migraine aura is one of the most universally thought of symptoms of migraine by the general public, despite affecting less than 30% of migraine sufferers. […] In several large population based studies in Denmark researchers found 32% of people who suffered migraine always suffered migraine with aura, while another 8% suffered both migraine with and without aura. A second study found that migraine aura with or without headache accounted for 38% of all migraine cases. […] A prospective diary study quantified migraine aura: 98% of respondents had visual symptoms (with 64% having 2 or more). Commonly reported were: 30% Flashes of bright light, 25% Foggy/blurred vision, 24% Zigzag or jagged lines, 23% Scotoma, 19% Phosphenes, 12% Flickering light. […] As you can see migraine aura extends to cover a wide range of presentations, with rarer examples being parosmia, dysphagia, dysgeusia, hypokinesia, paramnesia, auditory hallucinations and altered cognitive function.
- #34 Clinical features of visual migraine aura: a systematic review | The Journal of Headache and Pain | Full Texthttps://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-019-1008-x
Migraine with typical aura is a highly prevalent disorder as it affects 8% of the general population. Typical migraine aura (MA) symptoms are completely reversible visual, sensory, or language disturbances. Visual aura symptoms (VASs) are by far the most common and occur in 98-99% of MAs, whereas disturbances of sensation and language occur in 36% and 10% of auras, respectively. MA is associated with an increased risk of ischemic stroke, atrial fibrillation, and patent foramen ovale. It is also often clinically challenging to differentiate MA from other conditions, particularly transient ischemic attacks and occipital epilepsy. Improved clinical characterisation of MA will likely improve the diagnostic accuracy and identification of patient subgroups at risk of comorbidity. We systematically reviewed studies of VASs in order to create a list of all visual features reported during MA. We identified 14 studies, of which only three were prospective. The low number of prospective studies is a major limitation as the complex and polyhedral manifestations of MA are difficult to recall retrospectively. MA is a risk factor for several serious cardiovascular conditions, including ischemic and haemorrhagic stroke, myocardial infarction, atrial fibrillation and perioperative stroke. Moreover, the risk of vascular incidents increases up to 13 fold with the use of combined oral contraceptives, which is important considering that the majority of migraine patients are women of reproductive age. Therefore, it is of utmost importance to correctly diagnose patients with MA in order to effectively distinguish MA from other, potentially life-threatening, conditions. We emphasize the importance of an improved classification of migraine VASs and propose that an official list of visual symptoms should be developed for this purpose, preferably within the context of the International Classification of Headache Disorders of the International Headache Society.
- #35 Migraine with Aura | Melbourne Headache Centrehttps://melbourneheadachecentre.com.au/conditions/migraine-with-aura/
Migraine aura is one of the most universally thought of symptoms of migraine by the general public, despite affecting less than 30% of migraine sufferers. […] In several large population based studies in Denmark researchers found 32% of people who suffered migraine always suffered migraine with aura, while another 8% suffered both migraine with and without aura. A second study found that migraine aura with or without headache accounted for 38% of all migraine cases. […] A prospective diary study quantified migraine aura: 98% of respondents had visual symptoms (with 64% having 2 or more). Commonly reported were: 30% Flashes of bright light, 25% Foggy/blurred vision, 24% Zigzag or jagged lines, 23% Scotoma, 19% Phosphenes, 12% Flickering light. […] As you can see migraine aura extends to cover a wide range of presentations, with rarer examples being parosmia, dysphagia, dysgeusia, hypokinesia, paramnesia, auditory hallucinations and altered cognitive function.
- #36 Migraine with aura – PubMedhttps://pubmed.ncbi.nlm.nih.gov/34384631/
Around 15% to one-third of migraineurs experience aura. […] The relative risk of ischemic stroke is significantly increased in migraine with aura. […] Combined hormonal contraception with estrogens significantly increases the risk of stroke in women with migraine with aura. […] The prophylactic treatments for migraine with aura are those used in migraine without aura based on very few randomized clinical trials specifically dedicated to migraine with aura.
- #37 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
Migraine and stroke are two common and heterogeneous neurovascular disorders responsible for a significant burden for those affected and a great economic cost for the society. There is growing evidence that migraine increases the overall risk of cerebrovascular diseases. […] The risk of transient ischaemic attack also seems to be increased in people with migraine, although this issue has not been extensively investigated. […] In light of the higher risk of stroke in people with migraine with aura, it is important to identify and modify any vascular risk factor. […] Numerous studies, including five meta-analyses, have linked migraine, particularly migraine with aura (MA), with increased risk of ischaemic stroke. The relative risk of ischaemic stroke is doubled in people with MA compared with migraine-free individuals.
- #38 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
The association between migraine and ischaemic stroke is stronger for women, women younger than 45 years, women who use oral contraceptives and women who smoke. […] The risk is greater for those with active migraine (ie, migraine attack the last 12 months) and higher frequency of attacks; however, there is no conclusive evidence that the severity of migraine attacks influence the risk of ischaemic stroke. […] The classification of migraine and specifically MA in population-based studies is challenging. However, the consistent findings of the association between MA and ischaemic stroke across various study designs and classification schemes make a systematic bias unlikely. […] MA in women younger than age of 45 years and late onset of MA increase the risk of ischaemic stroke. Active migraine and increased attack frequency increase the risk of ischaemic stroke.
- #39 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
The association between migraine and ischaemic stroke is stronger for women, women younger than 45 years, women who use oral contraceptives and women who smoke. […] The risk is greater for those with active migraine (ie, migraine attack the last 12 months) and higher frequency of attacks; however, there is no conclusive evidence that the severity of migraine attacks influence the risk of ischaemic stroke. […] The classification of migraine and specifically MA in population-based studies is challenging. However, the consistent findings of the association between MA and ischaemic stroke across various study designs and classification schemes make a systematic bias unlikely. […] MA in women younger than age of 45 years and late onset of MA increase the risk of ischaemic stroke. Active migraine and increased attack frequency increase the risk of ischaemic stroke.
- #40 Migraine with Aura | American Headache Societyhttps://americanheadachesociety.org/resources/primary-care/migraine-with-aura
Approximately one-third of those with migraine experience aura, a sensory experience that occurs before or during an attack. […] Its important to correctly identify aura because those who have migraine with aura can potentially turn chronic, have a higher risk of stroke, and should have a different treatment plan. […] A team of researchers working in France and the U.S. has demonstrated in a large prospective study that women who experience migraine with aura are at greater risk of all types of stroke including ischemic and hemorrhagic stroke as well as all strokes.
- #41 Transient ischemic attack or migraine with aura? | Tidsskrift for Den norske legeforeninghttps://tidsskriftet.no/en/2023/10/clinical-review/transient-ischemic-attack-or-migraine-aura
Migraine with aura is a common stroke mimic and often the basis for acute thrombolytic therapy. […] In one review, where just under 7 % of patients had received improper thrombolytic treatments, migraine with aura accounted for 18 %. […] Migraine with aura: the criteria for typical migraine with aura have high sensitivity and high specificity. […] Around 30 % of migraine sufferers experience migraine with aura. […] Migraine has been identified as an independent risk factor for high-signal changes, especially in patients who experience aura. […] Migraine with aura can, in most cases, be distinguished from TIA by the gradual onset of symptoms with typical characteristics, sequence and duration.
- #42 Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study | The BMJhttps://www.bmj.com/content/342/bmj.c7357
Of the 116 participants with migraine, 17 (14.7%) reported aura symptoms. […] Migraine with aura was the only headache type strongly associated with volume of deep white matter hyperintensities (highest third odds ratio 12.4, 1.6 to 99.4, P for trend 0.005) and with brain infarcts (3.4, 1.2 to 9.3). […] Only participants who had migraine with aura had over a threefold increased risk (3.4, 1.2 to 9.3). […] Associations between migraine and brain infarcts is limited to people who have migraine with aura.
- #43 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
The presence of a headache after transient neurological symptoms does not necessarily mean that these symptoms are consistent with a diagnosis of MA, because a migraine-like attack (with or without aura) can also be triggered by ischaemic vascular events. […] Although some studies found increased risk in people with MA, there is overall not sufficient evidence that the risk of haemorrhagic stroke is particularly increased for MA. […] While women under the age of 45 years may be at increased risk of haemorrhagic stroke, the overall relationship between migraine and haemorrhagic stroke and the specific relationship between migraine subtypes and haemorrhagic stroke are uncertain. […] There is growing evidence of an association between migraine and other cardiovascular disorders including myocardial infarction, hypertension, venous thromboembolism and atrial fibrillation, with stronger association in people with MA.
- #44 Women With Migraine, Aura Have Increased Risk of Cardiovascular Deathhttps://www.ajmc.com/view/women-with-migraine-aura-have-increased-risk-of-cardiovascular-death
Women who experience migraine with aura have an increased hazard of cardiovascular diseasespecific mortality compared with individuals with no history of headache, according to a study published in The Journal of Headache and Pain. […] Migraine disproportionately affects women and may be a risk factor for CVD. […] Researchers concluded that future studies should investigate the underlying reasons for the observed increased risk of cardiovascular mortality among migraineurs with aura.
- #45 Migraine – Statistical and Genomic Epidemiology Laboratory (SGEL)https://research.qut.edu.au/sgel/research/migraine/
Migraine is a highly prevalent disorder with frequent attacks. Nearly one in four people (up to 33% of women and 13% of men), will have recurring attacks of migraine during their life. The 2015 Global Burden of Disease (GDB) study estimated the global prevalence of active migraineurs (i.e., attacks in the past year) at 13.6% (17.7% of women and 9.5% of men); in Australia, the prevalence was estimated at 19.3% (26.5% of women and 11.7% all men). […] One in ten migraineurs will develop chronic migraine with migraine headaches on at least 15 days a month. […] Migraine is the seventh leading cause of years of life lost to disability worldwide, and the third cause of disability in under 50s. Migraine is the leading cause of disability among neurological disorders, accounting for over half of all years lived with disability. […] The total annual economic cost of migraine in Australia is $35.7bn, comprising $14.3bn in health system costs, $16.3bn in productivity costs, and $5.1bn in other costs.
- #46 Migraine – Statistical and Genomic Epidemiology Laboratory (SGEL)https://research.qut.edu.au/sgel/research/migraine/
Migraine is a highly prevalent disorder with frequent attacks. Nearly one in four people (up to 33% of women and 13% of men), will have recurring attacks of migraine during their life. The 2015 Global Burden of Disease (GDB) study estimated the global prevalence of active migraineurs (i.e., attacks in the past year) at 13.6% (17.7% of women and 9.5% of men); in Australia, the prevalence was estimated at 19.3% (26.5% of women and 11.7% all men). […] One in ten migraineurs will develop chronic migraine with migraine headaches on at least 15 days a month. […] Migraine is the seventh leading cause of years of life lost to disability worldwide, and the third cause of disability in under 50s. Migraine is the leading cause of disability among neurological disorders, accounting for over half of all years lived with disability. […] The total annual economic cost of migraine in Australia is $35.7bn, comprising $14.3bn in health system costs, $16.3bn in productivity costs, and $5.1bn in other costs.
- #47 Migraine – Statistical and Genomic Epidemiology Laboratory (SGEL)https://research.qut.edu.au/sgel/research/migraine/
Migraine is a highly prevalent disorder with frequent attacks. Nearly one in four people (up to 33% of women and 13% of men), will have recurring attacks of migraine during their life. The 2015 Global Burden of Disease (GDB) study estimated the global prevalence of active migraineurs (i.e., attacks in the past year) at 13.6% (17.7% of women and 9.5% of men); in Australia, the prevalence was estimated at 19.3% (26.5% of women and 11.7% all men). […] One in ten migraineurs will develop chronic migraine with migraine headaches on at least 15 days a month. […] Migraine is the seventh leading cause of years of life lost to disability worldwide, and the third cause of disability in under 50s. Migraine is the leading cause of disability among neurological disorders, accounting for over half of all years lived with disability. […] The total annual economic cost of migraine in Australia is $35.7bn, comprising $14.3bn in health system costs, $16.3bn in productivity costs, and $5.1bn in other costs.
- #48 Migraine Headache: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/1142556-overview
A study by Hsu et al suggests that women aged 40-50 years are also more susceptible to migrainous vertigo. […] The prevalence of migraine appears to be lower among African Americans and Asian Americans than among whites. […] The economic cost resulting from migraine-related loss of productive time in the US workforce is more than $13 billion per year, most of which is in the form of reduced work productivity. […] The World Health Organization (WHO) estimates the worldwide prevalence of current migraine to be 10% and the lifetime prevalence to be 14%. The adjusted prevalence of migraine is highest in North America, followed by South and Central America, Europe, Asia, and Africa. […] Approximately 3000 migraine attacks per million persons worldwide occur every day. According to the WHO, migraine is 19th among all causes of years lived with disability. […] In the United States, migraine prevalence is inversely correlated with household income and level of education. Internationally, however, a relationship between migraine and socioeconomic status is not present.
- #49 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
The QRISK3 algorithm was recently developed and validated to predict 10-year risk of cardiovascular disease in men and women aged 25-84 years. […] Migraine being included in this algorithm indicates its importance in the risk prediction of cardiovascular disease. […] Most migraine patients have MO and are of no or little increased risk of stroke, and they should be reassured instead of being frightened. […] People with MA are at increased risk of developing cardio/cerebrovascular disease, and while migraine prevention in people with MA has not been shown to reduce stroke risk, management of vascular risk factors in those with MA is important in reducing stroke risk. […] Migraine and particularly MA have been consistently linked with increased risk of ischaemic stroke. An increased risk has also been observed for haemorrhagic stroke and cardiovascular disease. […] Based on the current evidence, MA should be considered an important risk marker for stroke.
- #50 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
The QRISK3 algorithm was recently developed and validated to predict 10-year risk of cardiovascular disease in men and women aged 25-84 years. […] Migraine being included in this algorithm indicates its importance in the risk prediction of cardiovascular disease. […] Most migraine patients have MO and are of no or little increased risk of stroke, and they should be reassured instead of being frightened. […] People with MA are at increased risk of developing cardio/cerebrovascular disease, and while migraine prevention in people with MA has not been shown to reduce stroke risk, management of vascular risk factors in those with MA is important in reducing stroke risk. […] Migraine and particularly MA have been consistently linked with increased risk of ischaemic stroke. An increased risk has also been observed for haemorrhagic stroke and cardiovascular disease. […] Based on the current evidence, MA should be considered an important risk marker for stroke.
- #51 Clinical features of migraine with aura: a REFORM study | The Journal of Headache and Pain | Full Texthttps://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01718-1
Among those with migraine, about one-third experience migraine with aura (MA), characterized by transient neurologic symptoms. […] While the 3rd edition of the International Classification of Headache Disorders (ICHD-3) provides valuable insights into the clinical features of aura, the available evidence from observational studies often lacks the detail necessary for a thorough understanding. […] Addressing this critical gap is paramount to improving disease characterization and enabling accurate diagnoses in clinical practice. […] Our findings will thus provide valuable insights for clinical practice and serve as a foundation for further research in this field. […] The study protocol received approval from the Health Research Ethics Committee of the Capital Region of Denmark, and all participants provided written informed consent before undergoing any study-related assessments or procedures.
- #52 Clinical features of visual migraine aura: a systematic review | The Journal of Headache and Pain | Full Texthttps://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-019-1008-x
Migraine with typical aura is a highly prevalent disorder as it affects 8% of the general population. Typical migraine aura (MA) symptoms are completely reversible visual, sensory, or language disturbances. Visual aura symptoms (VASs) are by far the most common and occur in 98-99% of MAs, whereas disturbances of sensation and language occur in 36% and 10% of auras, respectively. MA is associated with an increased risk of ischemic stroke, atrial fibrillation, and patent foramen ovale. It is also often clinically challenging to differentiate MA from other conditions, particularly transient ischemic attacks and occipital epilepsy. Improved clinical characterisation of MA will likely improve the diagnostic accuracy and identification of patient subgroups at risk of comorbidity. We systematically reviewed studies of VASs in order to create a list of all visual features reported during MA. We identified 14 studies, of which only three were prospective. The low number of prospective studies is a major limitation as the complex and polyhedral manifestations of MA are difficult to recall retrospectively. MA is a risk factor for several serious cardiovascular conditions, including ischemic and haemorrhagic stroke, myocardial infarction, atrial fibrillation and perioperative stroke. Moreover, the risk of vascular incidents increases up to 13 fold with the use of combined oral contraceptives, which is important considering that the majority of migraine patients are women of reproductive age. Therefore, it is of utmost importance to correctly diagnose patients with MA in order to effectively distinguish MA from other, potentially life-threatening, conditions. We emphasize the importance of an improved classification of migraine VASs and propose that an official list of visual symptoms should be developed for this purpose, preferably within the context of the International Classification of Headache Disorders of the International Headache Society.
- #53 Transient ischemic attack or migraine with aura? | Tidsskrift for Den norske legeforeninghttps://tidsskriftet.no/en/2023/10/clinical-review/transient-ischemic-attack-or-migraine-aura
Migraine with aura is a common stroke mimic and often the basis for acute thrombolytic therapy. […] In one review, where just under 7 % of patients had received improper thrombolytic treatments, migraine with aura accounted for 18 %. […] Migraine with aura: the criteria for typical migraine with aura have high sensitivity and high specificity. […] Around 30 % of migraine sufferers experience migraine with aura. […] Migraine has been identified as an independent risk factor for high-signal changes, especially in patients who experience aura. […] Migraine with aura can, in most cases, be distinguished from TIA by the gradual onset of symptoms with typical characteristics, sequence and duration.
- #54 Migraine with Aura | American Headache Societyhttps://americanheadachesociety.org/resources/primary-care/migraine-with-aura
Approximately one-third of those with migraine experience aura, a sensory experience that occurs before or during an attack. […] Its important to correctly identify aura because those who have migraine with aura can potentially turn chronic, have a higher risk of stroke, and should have a different treatment plan. […] A team of researchers working in France and the U.S. has demonstrated in a large prospective study that women who experience migraine with aura are at greater risk of all types of stroke including ischemic and hemorrhagic stroke as well as all strokes.
- #55 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
The association between migraine and ischaemic stroke is stronger for women, women younger than 45 years, women who use oral contraceptives and women who smoke. […] The risk is greater for those with active migraine (ie, migraine attack the last 12 months) and higher frequency of attacks; however, there is no conclusive evidence that the severity of migraine attacks influence the risk of ischaemic stroke. […] The classification of migraine and specifically MA in population-based studies is challenging. However, the consistent findings of the association between MA and ischaemic stroke across various study designs and classification schemes make a systematic bias unlikely. […] MA in women younger than age of 45 years and late onset of MA increase the risk of ischaemic stroke. Active migraine and increased attack frequency increase the risk of ischaemic stroke.
- #56 Clinical features of visual migraine aura: a systematic review | The Journal of Headache and Pain | Full Texthttps://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-019-1008-x
Migraine with typical aura is a highly prevalent disorder as it affects 8% of the general population. Typical migraine aura (MA) symptoms are completely reversible visual, sensory, or language disturbances. Visual aura symptoms (VASs) are by far the most common and occur in 98-99% of MAs, whereas disturbances of sensation and language occur in 36% and 10% of auras, respectively. MA is associated with an increased risk of ischemic stroke, atrial fibrillation, and patent foramen ovale. It is also often clinically challenging to differentiate MA from other conditions, particularly transient ischemic attacks and occipital epilepsy. Improved clinical characterisation of MA will likely improve the diagnostic accuracy and identification of patient subgroups at risk of comorbidity. We systematically reviewed studies of VASs in order to create a list of all visual features reported during MA. We identified 14 studies, of which only three were prospective. The low number of prospective studies is a major limitation as the complex and polyhedral manifestations of MA are difficult to recall retrospectively. MA is a risk factor for several serious cardiovascular conditions, including ischemic and haemorrhagic stroke, myocardial infarction, atrial fibrillation and perioperative stroke. Moreover, the risk of vascular incidents increases up to 13 fold with the use of combined oral contraceptives, which is important considering that the majority of migraine patients are women of reproductive age. Therefore, it is of utmost importance to correctly diagnose patients with MA in order to effectively distinguish MA from other, potentially life-threatening, conditions. We emphasize the importance of an improved classification of migraine VASs and propose that an official list of visual symptoms should be developed for this purpose, preferably within the context of the International Classification of Headache Disorders of the International Headache Society.
- #57 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
The presence of a headache after transient neurological symptoms does not necessarily mean that these symptoms are consistent with a diagnosis of MA, because a migraine-like attack (with or without aura) can also be triggered by ischaemic vascular events. […] Although some studies found increased risk in people with MA, there is overall not sufficient evidence that the risk of haemorrhagic stroke is particularly increased for MA. […] While women under the age of 45 years may be at increased risk of haemorrhagic stroke, the overall relationship between migraine and haemorrhagic stroke and the specific relationship between migraine subtypes and haemorrhagic stroke are uncertain. […] There is growing evidence of an association between migraine and other cardiovascular disorders including myocardial infarction, hypertension, venous thromboembolism and atrial fibrillation, with stronger association in people with MA.
- #58 Clinical features of visual migraine aura: a systematic review | The Journal of Headache and Pain | Full Texthttps://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-019-1008-x
Migraine with typical aura is a highly prevalent disorder as it affects 8% of the general population. Typical migraine aura (MA) symptoms are completely reversible visual, sensory, or language disturbances. Visual aura symptoms (VASs) are by far the most common and occur in 98-99% of MAs, whereas disturbances of sensation and language occur in 36% and 10% of auras, respectively. MA is associated with an increased risk of ischemic stroke, atrial fibrillation, and patent foramen ovale. It is also often clinically challenging to differentiate MA from other conditions, particularly transient ischemic attacks and occipital epilepsy. Improved clinical characterisation of MA will likely improve the diagnostic accuracy and identification of patient subgroups at risk of comorbidity. We systematically reviewed studies of VASs in order to create a list of all visual features reported during MA. We identified 14 studies, of which only three were prospective. The low number of prospective studies is a major limitation as the complex and polyhedral manifestations of MA are difficult to recall retrospectively. MA is a risk factor for several serious cardiovascular conditions, including ischemic and haemorrhagic stroke, myocardial infarction, atrial fibrillation and perioperative stroke. Moreover, the risk of vascular incidents increases up to 13 fold with the use of combined oral contraceptives, which is important considering that the majority of migraine patients are women of reproductive age. Therefore, it is of utmost importance to correctly diagnose patients with MA in order to effectively distinguish MA from other, potentially life-threatening, conditions. We emphasize the importance of an improved classification of migraine VASs and propose that an official list of visual symptoms should be developed for this purpose, preferably within the context of the International Classification of Headache Disorders of the International Headache Society.
- #59 Daily briefing: Spinal fluid causes aural migraine pain, suggests research in micehttps://www.nature.com/articles/d41586-024-02257-0
Research in mice hints at how brain activity triggers aural migraines. It suggests that the aura phase before the headache when people experience symptoms such as blind spots temporarily changes the content of the cerebrospinal fluid, the clear liquid that surrounds the brain and spinal cord. […] This altered fluid, researchers suggest, travels through a previously unknown gap in anatomy to nerves in the skull where it activates pain and inflammatory receptors. […] Migraine is actually protective in that it signals something abnormal is happening in the brain, says neuroscientist and study co-author Maiken Nedergaard. The pain is protective because its telling the person to rest and recover and sleep.
- #60 Migraine aura, a predictor of near-death experiences in a crowdsourced study | bioRxivhttps://www.biorxiv.org/content/10.1101/811885v1.full-text
Migraine aura was a predictor of NDE in our sample. […] The only significant association was between confirmed NDE and migraine aura: Forty-eight (6.1%) of 783 subjects without migraine aura and 33 (13.0%) of 254 subjects with migraine aura had experienced an NDE (p<0.001, chi-square test, odds ratio = 2.29). [...] In multiple logistic regression analysis with age, gender and the interaction of age and gender, none of these potential predictors was significant. However, migraine aura remained significant after adjustment for age (p<0.001, odds ratio = 2.31), gender (p<0.001, odds ratio = 2.33), and both age and gender (p<0.001, odds ratio = 2.33). [...] The prevalence of individuals with an NDE is estimated at about 4-8% in the general population. [...] In our survey it was 8%. [...] The high prevalence of primary headaches in our survey is hence within the realm of possibility but raises the question if we have attracted a disproportionate number of people with headache.
- #61https://journals.lww.com/epidem/fulltext/2013/05000/is_autism_linked_to_migraine_aura_.30.aspx
After nearly seven decades of investigation, autism continues to be a widespread disorder of childhood with no known cause. A review of recent research suggests that migraine with aura could be a mechanism beginning in early infancy that contributes to the fear-conflict patterns and developmental failures associated with infant autism. […] The sudden loss of sight, unexplained movements, and zig-zag patterns of migraine with aura may upset the unique dynamics of successful attachment between mother and child. […] It is possible that the experience of migraine aura disturbs the infants perception of a stable reality and threatens the security of the mother-child relationship. Further research is encouraged to explore the potential relationship between migraine with aura and infant autism. If such a link exists, it could lead to significant advances in diagnosis, early treatment, and prevention of this childhood disorder.
- #62 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
Migraine and stroke are two common and heterogeneous neurovascular disorders responsible for a significant burden for those affected and a great economic cost for the society. There is growing evidence that migraine increases the overall risk of cerebrovascular diseases. […] The risk of transient ischaemic attack also seems to be increased in people with migraine, although this issue has not been extensively investigated. […] In light of the higher risk of stroke in people with migraine with aura, it is important to identify and modify any vascular risk factor. […] Numerous studies, including five meta-analyses, have linked migraine, particularly migraine with aura (MA), with increased risk of ischaemic stroke. The relative risk of ischaemic stroke is doubled in people with MA compared with migraine-free individuals.
- #63 Migraine with aura – PubMedhttps://pubmed.ncbi.nlm.nih.gov/34384631/
Around 15% to one-third of migraineurs experience aura. […] The relative risk of ischemic stroke is significantly increased in migraine with aura. […] Combined hormonal contraception with estrogens significantly increases the risk of stroke in women with migraine with aura. […] The prophylactic treatments for migraine with aura are those used in migraine without aura based on very few randomized clinical trials specifically dedicated to migraine with aura.
- #64 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
The association between migraine and ischaemic stroke is stronger for women, women younger than 45 years, women who use oral contraceptives and women who smoke. […] The risk is greater for those with active migraine (ie, migraine attack the last 12 months) and higher frequency of attacks; however, there is no conclusive evidence that the severity of migraine attacks influence the risk of ischaemic stroke. […] The classification of migraine and specifically MA in population-based studies is challenging. However, the consistent findings of the association between MA and ischaemic stroke across various study designs and classification schemes make a systematic bias unlikely. […] MA in women younger than age of 45 years and late onset of MA increase the risk of ischaemic stroke. Active migraine and increased attack frequency increase the risk of ischaemic stroke.
- #65 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
The QRISK3 algorithm was recently developed and validated to predict 10-year risk of cardiovascular disease in men and women aged 25-84 years. […] Migraine being included in this algorithm indicates its importance in the risk prediction of cardiovascular disease. […] Most migraine patients have MO and are of no or little increased risk of stroke, and they should be reassured instead of being frightened. […] People with MA are at increased risk of developing cardio/cerebrovascular disease, and while migraine prevention in people with MA has not been shown to reduce stroke risk, management of vascular risk factors in those with MA is important in reducing stroke risk. […] Migraine and particularly MA have been consistently linked with increased risk of ischaemic stroke. An increased risk has also been observed for haemorrhagic stroke and cardiovascular disease. […] Based on the current evidence, MA should be considered an important risk marker for stroke.
- #66 Migraine and risk of stroke | Journal of Neurology, Neurosurgery & Psychiatryhttps://jnnp.bmj.com/content/91/6/593
The QRISK3 algorithm was recently developed and validated to predict 10-year risk of cardiovascular disease in men and women aged 25-84 years. […] Migraine being included in this algorithm indicates its importance in the risk prediction of cardiovascular disease. […] Most migraine patients have MO and are of no or little increased risk of stroke, and they should be reassured instead of being frightened. […] People with MA are at increased risk of developing cardio/cerebrovascular disease, and while migraine prevention in people with MA has not been shown to reduce stroke risk, management of vascular risk factors in those with MA is important in reducing stroke risk. […] Migraine and particularly MA have been consistently linked with increased risk of ischaemic stroke. An increased risk has also been observed for haemorrhagic stroke and cardiovascular disease. […] Based on the current evidence, MA should be considered an important risk marker for stroke.
- #67 Migraine with aura – PubMedhttps://pubmed.ncbi.nlm.nih.gov/34384631/
Around 15% to one-third of migraineurs experience aura. […] The relative risk of ischemic stroke is significantly increased in migraine with aura. […] Combined hormonal contraception with estrogens significantly increases the risk of stroke in women with migraine with aura. […] The prophylactic treatments for migraine with aura are those used in migraine without aura based on very few randomized clinical trials specifically dedicated to migraine with aura.
- #68 Migraine Market Size Projected to Grow Rapidly by 2034, Drivenhttps://www.openpr.com/news/4006021/migraine-market-size-projected-to-grow-rapidly-by-2034-driven
Migraine Market Insight, Epidemiology And Market Forecast – 2034 […] The migraine patient population continues to expand, with approximately 120K prevalent cases reported across the 7MM in 2023. The US represents the largest patient share at nearly 40%, followed by Japan at 15%. The UK leads among European nations. Furthermore, gender disparities remain pronounced, with females constituting approximately three times the number of cases compared to males in the US. Epidemiological patterns further reveal that episodic migraine significantly outweighs chronic migraine in prevalence. […] The identification of key biomarkers, particularly serotonin 1F receptor and calcitonin gene-related peptide (CGRP), has revolutionised treatment approaches, with CGRP antagonists like Eli Lilly’s EMGALITY (galcanezumab-gnlm) and Teva’s AJOVY (fremanezumab-vfrm) securing significant market share.